Gear Up for Marathon Petroleum (MPC) Q2 Earnings: Wall Street Estimates for Key Metrics

Marathon Petroleum (MPC) is projected to report Q2 earnings of $3.22 per share, a 21.8% year-over-year decline, on revenues of $30.91 billion, down 19.4%. Despite these anticipated year-over-year declines, the consensus EPS estimate has seen a significant 22.9% upward revision over the past 30 days, indicating a re-appraisal by analysts. Operational forecasts include a decrease in net refinery throughput to 2,950.66 thousand barrels per day and a decline in Refining & Marketing Adjusted EBITDA to $1.49 billion, while Midstream Adjusted EBITDA is expected to increase to $1.67 billion. MPC shares have underperformed the S&P 500 over the past month, returning -6% versus the S&P's +0.6%, and currently hold a Zacks Rank #3 (Hold).

Analysis

Marathon Petroleum (MPC) is approaching its Q2 earnings release with expectations of a significant year-over-year contraction, yet with underlying signals of improving analyst sentiment. Wall Street projects a 21.8% decline in quarterly earnings to $3.22 per share and a 19.4% drop in revenues to $30.91 billion. This anticipated weakness is rooted in the core Refining & Marketing segment, where Adjusted EBITDA is forecast to fall to $1.49 billion from $1.97 billion, and net refinery throughput is expected to decrease to 2,950.66 thousand barrels per day from 3,065.00 thousand in the prior year. However, a critical counter-narrative is the substantial 22.9% upward revision in the consensus EPS estimate over the past 30 days, suggesting that initial pessimism may have been over-stated and that near-term conditions are viewed more favorably. This positive revision contrasts sharply with the stock's recent -6% return over the past month, which underperformed the S&P 500. Further, the company's Midstream segment is a source of stability, with its Adjusted EBITDA projected to grow to $1.67 billion from $1.62 billion, partially offsetting the volatility in refining.

Key Decisions for Investors

• Investors should weigh the significant 22.9% upward revision in consensus EPS estimates against the stock's recent -6% underperformance, as this positive momentum could trigger a favorable reaction if earnings meet the revised, higher expectations.
• Pay close attention to the performance of the Midstream segment, as its expected EBITDA growth to $1.67 billion provides a crucial element of stability and diversification against the cyclical downturn in the Refining & Marketing business.
• Given the conflicting signals of negative year-over-year comparisons versus strong positive estimate revisions, a prudent approach would be to wait for the official earnings release and management's forward guidance before making significant portfolio adjustments.